78 results
424B3
BTMD
biote Corp - Ordinary Shares
10 May 24
Prospectus supplement
4:12pm
that management believes is relevant to an assessment and understanding of our consolidated results of operations and financial condition. You should … was an adulterated and misbranded medical device because the agency disagreed with Abiomed’s assessment that the software product was non-device CDS
424B3
BTMD
biote Corp - Ordinary Shares
10 May 24
Prospectus supplement
4:10pm
that management believes is relevant to an assessment and understanding of our consolidated results of operations and financial condition. You should … was an adulterated and misbranded medical device because the agency disagreed with Abiomed’s assessment that the software product was non-device CDS
424B3
BTMD
biote Corp - Ordinary Shares
9 Apr 24
Prospectus supplement
4:28pm
that Abiomed’s software was an adulterated and misbranded medical device because the agency disagreed with Abiomed’s assessment that the software … , patches), oral methods (sublingual tablets, pills) or injections, depending on the practitioners’ medical assessment of their patients’ clinical needs
424B3
yozjf1ixb858grmeh
9 Apr 24
Prospectus supplement
4:25pm
POS AM
EX-10.22
m4if1a w75azop13qu
29 Mar 24
Prospectus update (post-effective amendment)
5:34pm
POS AM
g0v50ahjmjag5c5b x4
29 Mar 24
Prospectus update (post-effective amendment)
5:34pm
POS AM
abz0jz zxr
29 Mar 24
Prospectus update (post-effective amendment)
5:34pm
POS AM
EX-10.22
rj9dpotoo2xi3vs2y
29 Mar 24
Prospectus update (post-effective amendment)
5:34pm
424B3
w8tmig 8p5k5go4s
13 Nov 23
Prospectus supplement
6:44pm
424B3
hvode
13 Nov 23
Prospectus supplement
6:43pm
424B3
7bazctt1t8r
11 Aug 23
Prospectus supplement
3:55pm
424B3
63l l1fqu9l1n8y
11 Aug 23
Prospectus supplement
3:55pm
424B3
gar82
7 Jun 23
Prospectus supplement
9:15am